Robert A. Anders
- Oncology top 0.02%
- Cancer Immunotherapy and Biomarkers 76
- Pancreatic and Hepatic Oncology Research 33
- CAR-T cell therapy research 19
- Immunology top 0.1%
- Immunotherapy and Immune Responses 35
- Cell Biology top 0.1%
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 33
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 20
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 28
-
- Liver Disease Diagnosis and Treatment 24
- Co-authors
- Janis M. TaubeDrew M. PardollSuzanne L. TopalianDuojia PanLieping ChenHaiying XuJulie R. BrahmerAnirban Maitra
- Cited by
- OncologyImmunologyCell Biology
- Journals
- Journal of Clinical Oncology (22 papers)Cancer Research (11 papers)Cancer Immunology Research (10 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Robert A. Anders
262 papers receiving 28.2k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Oncology 16.0k
- Immunology 8.5k
- Cell Biology 4.5k
- Hepatology 1.7k
- Cancer Research 3.1k
Countries citing papers authored by Robert A. Anders
This map shows the geographic impact of Robert A. Anders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Anders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Anders more than expected).
Fields of papers citing papers by Robert A. Anders
This network shows the impact of papers produced by Robert A. Anders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Anders. The network helps show where Robert A. Anders may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert A. Anders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 6 | |
| 3 | 2019 | 32 | |
| 4 | 2019 | 12 | |
| 5 | 2019 | 180 | |
| 6 | 2019 | 92 | |
| 7 | 2017 | 109 | |
| 8 | 2017 | 166 | |
| 9 | 2017 | 28 | |
| 10 | 2016 | 92 | |
| 11 | Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stromabreakdown → | 2016 | 359 |
| 12 | 2016 | 133 | |
| 13 | 2016 | 19 | |
| 14 | 2015 | 52 | |
| 15 | 2014 | 399 | |
| 16 | 2014 | 42 | |
| 17 | Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapybreakdown → | 2014 | 1873 |
| 18 | 2011 | 60 | |
| 19 | 2009 | 122 | |
| 20 | 2006 | 62 |
About Robert A. Anders
Robert A. Anders is a scholar working on Hepatology, Oncology and Immunology, having authored 272 papers that have together received 28.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (76 papers), Immunotherapy and Immune Responses (35 papers), Pancreatic and Hepatic Oncology Research (33 papers), Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers), Liver Disease Diagnosis and Treatment (24 papers), Cancer Genomics and Diagnostics (20 papers) and CAR-T cell therapy research (19 papers). The work is most often cited by research in Oncology (16.0k citations), Immunology (8.5k citations) and Cell Biology (4.5k citations). Robert A. Anders has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Janis M. Taube, Drew M. Pardoll, Suzanne L. Topalian, Duojia Pan, Lieping Chen, Haiying Xu, Julie R. Brahmer, Anirban Maitra, Jixin Dong and Tracee L. McMiller. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer Immunology Research, The American Journal of Surgical Pathology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.